Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
Related ArticlesFFB Pledges $300,000 to Support Dr. Yi-Zhong Wang’s Artificial Intelligence/ Deep Machine Learning Project Macular Degeneration Stem Cell Clinical Trial Results Allow for Phase II Expansion 20 Years of Racing for Sight Early Detection and Treatment for Pediatric Eye Conditions – Video Update Retina Foundation CEO Shares Fundraising Goals to Preserve and Save Vision